FINAL EXAM QUESTIONS WITH
CORRECT SOLUTIONS||100%
GUARANTEED PASS||ALREADY
GRADED A+||UPDATED 2026/2027
SYLLABUS||<<NEWEST VERSION>>
Review the primary drugs used to decrease pain and inflammation in rheumatoid
arthritis (RA)? - ANSWER ✓ Pain and inflammation are often managed with
NSAIDs and low-dose corticosteroids, used as adjuncts to disease-modifying
therapy to control symptoms, especially during disease flares.
Introduce the drugs used to decrease disease progression in RA? - ANSWER ✓
Disease progression is targeted with disease-modifying antirheumatic drugs
(DMARDs) such as methotrexate, sulfasalazine, leflunomide, hydroxychloroquine,
and biologic or targeted synthetic DMARDs that inhibit specific immune
pathways.
Articulate the rationale for administering insulin to people with type 1 diabetes
mellitus? - ANSWER ✓ In type 1 DM, pancreatic beta cells are destroyed, leading
to absolute insulin deficiency; exogenous insulin is required to regulate blood
glucose, prevent ketoacidosis, and allow normal metabolism and growth.
Consider how technological advancements have improved the methods used to
deliver insulin? - ANSWER ✓ Advances include insulin pens, continuous
subcutaneous insulin infusion pumps, smart pumps with glucose sensor integration,
and continuous glucose monitoring systems that improve dosing precision,
convenience, and glycemic control.
Categorize the drugs used to help control blood glucose levels in people with type
2 DM? - ANSWER ✓ Drug classes include metformin, sulfonylureas and other
secretagogues, thiazolidinediones, DPP-4 inhibitors, GLP-1 receptor agonists,
SGLT2 inhibitors, alpha-glucosidase inhibitors, and, when needed, insulin.
, Explain why exercise and dietary management should always be combined with
drug therapy in people with type 1 or type 2 DM? - ANSWER ✓ Diet and exercise
improve insulin sensitivity, assist with weight control, reduce cardiovascular risk,
and help stabilize blood glucose, enhancing the effectiveness of medications and
reducing required doses.
Identify clinical conditions that could be treated with androgen replacement? -
ANSWER ✓ Conditions include male hypogonadism due to primary or secondary
testicular failure, delayed puberty in males, certain muscle-wasting states, and
symptomatic testosterone deficiency with low serum levels.
Distinguish clinical uses of androgens from androgen abuse? - ANSWER ✓
Clinical use involves physiologic replacement under medical supervision to
normalize hormone levels and relieve deficiency symptoms, while abuse involves
supraphysiologic doses (often in athletes) to enhance performance or appearance,
leading to significant adverse effects.
Explain how female hormones can have contraceptive effects? - ANSWER ✓
Estrogen-progestin combinations suppress ovulation by inhibiting gonadotropin
release, and progestins thicken cervical mucus and alter endometrial lining,
reducing sperm penetration and implantation likelihood.
Articulate the benefits and potential risks of hormone replacement therapy? -
ANSWER ✓ Benefits include relief of vasomotor symptoms and prevention of
bone loss; risks can include increased likelihood of thromboembolism, stroke,
breast cancer, and cardiovascular events depending on regimen and patient factors.
Identify symptoms of over- or underdosing in patients receiving thyroid
replacement drugs? - ANSWER ✓ Overdosing can cause signs of hyperthyroidism
such as tachycardia, weight loss, heat intolerance, and nervousness; underdosing
can produce fatigue, weight gain, cold intolerance, bradycardia, and slowed
cognition.
Categorize the primary drugs used to maintain bone mineral density in conditions
such as osteoporosis? - ANSWER ✓ Key drugs include bisphosphonates, selective
estrogen receptor modulators (SERMs), denosumab, parathyroid hormone analogs
(e.g., teriparatide), and adequate calcium and vitamin D supplementation.
, Identify three primary structural or functional differences between bacterial cells
and human cells? - ANSWER ✓ Bacteria possess a rigid cell wall, have different
ribosomal structure (70S vs human 80S), and often synthesize unique metabolic
enzymes and pathways not present in human cells.
Categorize antibacterial drugs by the way they exert selective toxicity against
bacteria? - ANSWER ✓ Antibacterials can inhibit cell wall synthesis, disrupt cell
membrane integrity, inhibit bacterial protein synthesis, inhibit nucleic acid
synthesis, or block specific metabolic pathways like folate synthesis.
Discuss why bacteria become resistant to drugs, and what can be done to limit this
problem? - ANSWER ✓ Resistance arises through genetic mutation and gene
transfer, often driven by overuse and misuse of antibiotics; limiting resistance
requires appropriate prescribing, full treatment courses, infection control, and
antimicrobial stewardship.
List the primary adverse effects caused by antibacterial drugs? - ANSWER ✓
Common adverse effects include gastrointestinal upset, allergic reactions,
superinfections such as C. difficile, organ toxicity (e.g., hepatic, renal, ototoxicity),
and alterations of normal flora.
Consider why it is often more difficult to treat viral infections than other types of
infections? - ANSWER ✓ Viruses use host cell machinery to replicate, so there are
fewer unique viral targets, and inhibiting replication risks damaging host cells;
many viruses also integrate or persist latently.
Explain how anti-viral drugs slow viral replication in humans? - ANSWER ✓
Antiviral drugs interfere with specific viral processes such as attachment or entry,
uncoating, nucleic acid synthesis, protease-mediated processing, or release of new
virions, thereby slowing replication. Discuss how vaccines work?^Vaccines expose
the immune system to antigens or genetic instructions to induce specific immune
memory, so future exposure to the pathogen triggers a faster, stronger protective
response.
Categorize the primary drug strategies used to treat HIV infection? - ANSWER ✓
Major classes include reverse transcriptase inhibitors (NRTIs, NNRTIs), protease
inhibitors, integrase strand transfer inhibitors, entry or fusion inhibitors, and CCR5
antagonists.